- Home
- SBAC vs RPRX Comparison
SBAC vs RPRX Comparison
Compare SBAC & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBAC | RPRX |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 19.5B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SBAC | RPRX |
|---|---|---|
| Price | $200.29 | $48.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 4 |
| Target Price | ★ $230.53 | $47.75 |
| AVG Volume (30 Days) | 1.0M | ★ 2.8M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.45% | 1.94% |
| EPS Growth | ★ 41.21 | N/A |
| EPS | ★ 9.80 | 1.78 |
| Revenue | ★ $2,815,139,000.00 | $2,378,193,000.00 |
| Revenue This Year | $2.98 | $38.30 |
| Revenue Next Year | $2.48 | $4.80 |
| P/E Ratio | ★ $20.81 | $27.29 |
| Revenue Growth | 5.06 | 5.06 |
| 52 Week Low | $162.41 | $29.66 |
| 52 Week High | $245.13 | $49.06 |
Technical Indicators
Market Signals| Indicator | SBAC | RPRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.13 | 70.10 |
| Support Level | $184.52 | $35.32 |
| Resistance Level | $206.13 | N/A |
| Average True Range (ATR) | 6.78 | 0.89 |
| MACD | 1.61 | 0.17 |
| Stochastic Oscillator | 98.21 | 88.68 |
Price Performance
Historical ComparisonAbout SBAC SBA Communications Corporation
SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.